• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 ECM 促进肺肺泡模型的器官形成。

Soluble ECM promotes organotypic formation in lung alveolar model.

机构信息

Chemistry and Biochemistry, Brigham Young University, Ezra Taft Benson Building, Campus Drive, Provo, 84601, UT, USA.

Electrical and Computer Engineering Department, Brigham Young University, Provo, UT, 84602, USA.

出版信息

Biomaterials. 2022 Apr;283:121464. doi: 10.1016/j.biomaterials.2022.121464. Epub 2022 Mar 16.

DOI:10.1016/j.biomaterials.2022.121464
PMID:35306229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359416/
Abstract

Micropatterned suspension culture creates consistently sized and shaped cell aggregates but has not produced organotypic structures from stable cells, thus restricting its use in accurate disease modeling. Here, we show that organotypic structure is achieved in hybrid suspension culture via supplementation of soluble extracellular matrix (ECM). We created a viable lung organoid from epithelial, endothelial, and fibroblast human stable cell lines in suspension culture. We demonstrate the importance of soluble ECM in organotypic patterning with the emergence of lumen-like structures with airspace showing feasible gas exchange units, formation of branching, perfusable vasculature, and long-term 70-day maintenance of lumen structure. Our results show a dependent relationship between enhanced fibronectin fibril assembly and the incorporation of ECM in the organoid. We successfully applied this technology in modeling lung fibrosis via bleomycin induction and test a potential antifibrotic drug in vitro while maintaining fundamental cell-cell interactions in lung tissue. Our human fluorescent lung organoid (hFLO) model represents features of pulmonary fibrosis which were ameliorated by fasudil treatment. We also demonstrate a 3D culture method with potential of creating organoids from mature cells, thus opening avenues for disease modeling and regenerative medicine, enhancing understanding of lung cell biology in health and lung disease.

摘要

微图案悬浮培养可产生大小和形状一致的细胞聚集体,但不能从稳定细胞中产生器官型结构,从而限制了其在精确疾病建模中的应用。在这里,我们通过补充可溶细胞外基质 (ECM) 展示了混合悬浮培养中实现器官型结构的方法。我们从上皮细胞、内皮细胞和成纤维细胞的稳定细胞系在悬浮培养中创建了可行的肺类器官。我们通过出现具有气腔的腔样结构来证明可溶性 ECM 在器官型模式形成中的重要性,这些气腔显示出可行的气体交换单元、分支形成、可灌注的脉管系统以及腔结构的 70 天长期维持。我们的结果表明,增强纤维连接蛋白原纤维组装与 ECM 在类器官中的结合之间存在依赖性关系。我们通过博来霉素诱导成功地将这项技术应用于肺纤维化的建模中,并在维持肺组织中基本的细胞-细胞相互作用的同时,在体外测试了一种潜在的抗纤维化药物。我们的人荧光肺类器官 (hFLO) 模型代表了肺纤维化的特征,法舒地尔治疗改善了这些特征。我们还展示了一种具有从成熟细胞中创建类器官潜力的 3D 培养方法,从而为疾病建模和再生医学开辟了途径,增进了对健康和肺部疾病中肺细胞生物学的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/00ae89735977/nihms-1825649-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/1f83c6288960/nihms-1825649-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/3110e998a293/nihms-1825649-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/70577c91d371/nihms-1825649-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/26594562f692/nihms-1825649-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/797f1b029335/nihms-1825649-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/00ae89735977/nihms-1825649-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/1f83c6288960/nihms-1825649-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/3110e998a293/nihms-1825649-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/70577c91d371/nihms-1825649-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/26594562f692/nihms-1825649-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/797f1b029335/nihms-1825649-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b2c/9359416/00ae89735977/nihms-1825649-f0006.jpg

相似文献

1
Soluble ECM promotes organotypic formation in lung alveolar model.可溶性 ECM 促进肺肺泡模型的器官形成。
Biomaterials. 2022 Apr;283:121464. doi: 10.1016/j.biomaterials.2022.121464. Epub 2022 Mar 16.
2
Engineering de novo assembly of fetal pulmonary organoids.工程化胎儿肺类器官的从头组装。
Tissue Eng Part A. 2014 Nov;20(21-22):2892-907. doi: 10.1089/ten.TEA.2014.0085. Epub 2014 Jun 25.
3
Human airway organoid engineering as a step toward lung regeneration and disease modeling.人类气道类器官工程:迈向肺再生和疾病建模的一步。
Biomaterials. 2017 Jan;113:118-132. doi: 10.1016/j.biomaterials.2016.10.046. Epub 2016 Oct 28.
4
Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids.利用人多能干细胞衍生的肺泡类器官进行肺纤维化疾病建模。
Stem Cell Reports. 2021 Dec 14;16(12):2973-2987. doi: 10.1016/j.stemcr.2021.10.015. Epub 2021 Nov 18.
5
Testicular organoid formation is a property of immature somatic cells, which self-assemble and exhibit long-term hormone-responsive endocrine function.类睾丸器官的形成是未成熟体细胞的一种特性,这些细胞可以自我组装,并表现出长期的激素反应性内分泌功能。
Biofabrication. 2020 Jul 9;12(4):045002. doi: 10.1088/1758-5090/ab9907.
6
Extracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids.基于细胞外基质的水凝胶来定制肿瘤类器官。
ACS Biomater Sci Eng. 2021 Sep 13;7(9):4128-4135. doi: 10.1021/acsbiomaterials.0c01801. Epub 2021 Mar 16.
7
A perfusable, vascularized kidney organoid-on-chip model.可灌注、血管化的肾类器官芯片模型。
Biofabrication. 2024 Jul 5;16(4). doi: 10.1088/1758-5090/ad5ac0.
8
Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.Necrostatin-1 减轻博来霉素诱导的肺纤维化和细胞外基质表达在肺间质纤维化。
Med Sci Monit. 2020 Feb 5;26:e919739. doi: 10.12659/MSM.919739.
9
Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.细胞外基质交联增强成纤维细胞生长并防止肺纤维化中的基质蛋白水解。
Am J Respir Cell Mol Biol. 2018 May;58(5):594-603. doi: 10.1165/rcmb.2016-0379OC.
10
Distinct niches within the extracellular matrix dictate fibroblast function in (cell free) 3D lung tissue cultures.细胞外基质内的不同龛位决定了成纤维细胞在(无细胞)3D 肺组织培养物中的功能。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L708-L723. doi: 10.1152/ajplung.00408.2017. Epub 2018 Jan 18.

引用本文的文献

1
Best Practices in the Development and Use of Experimental Models of Bacterial Pneumonia: An Official American Thoracic Society Workshop Report.细菌性肺炎实验模型开发与应用的最佳实践:美国胸科学会官方研讨会报告
Am J Respir Cell Mol Biol. 2025 Aug;73(2):178-199. doi: 10.1165/rcmb.2025-0322ST.
2
Scalable Matrigel-Free Suspension Culture for Generating High-Quality Human Liver Ductal Organoids.用于生成高质量人肝导管类器官的可扩展无基质胶悬浮培养法
Cell Prolif. 2025 Sep;58(9):e70033. doi: 10.1111/cpr.70033. Epub 2025 Apr 1.
3
Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip.

本文引用的文献

1
The ECM: To Scaffold, or Not to Scaffold, That Is the Question.细胞外基质:构建还是不构建,这是个问题。
Int J Mol Sci. 2021 Nov 24;22(23):12690. doi: 10.3390/ijms222312690.
2
Pulmonary fibrosis distal airway epithelia are dynamically and structurally dysfunctional.肺纤维化导致远端气道上皮细胞的动态和结构功能障碍。
Nat Commun. 2021 Jul 27;12(1):4566. doi: 10.1038/s41467-021-24853-8.
3
An Improved Scalable Hydrogel Dish for Spheroid Culture.一种用于球体培养的改进型可扩展水凝胶培养皿。
类器官与微流控技术的结合:类器官芯片的最新进展、挑战与未来
In Vitro Model. 2025 Mar 5;4(1):71-88. doi: 10.1007/s44164-025-00086-7. eCollection 2025 Feb.
4
Integrated biocompatible 3D printed isoporous membranes with 7 μm pores.集成生物相容性 3D 打印的具有 7μm 孔径的各向同性多孔膜。
Lab Chip. 2024 Apr 16;24(8):2202-2207. doi: 10.1039/d4lc00014e.
5
Advanced lung organoids for respiratory system and pulmonary disease modeling.用于呼吸系统和肺部疾病建模的高级肺类器官
J Tissue Eng. 2024 Feb 22;15:20417314241232502. doi: 10.1177/20417314241232502. eCollection 2024 Jan-Dec.
6
CEBPA Overexpression Enhances β-Cell Proliferation and Survival.CEBPA过表达增强β细胞增殖和存活。
Biology (Basel). 2024 Feb 9;13(2):110. doi: 10.3390/biology13020110.
7
The evolution of models of lung fibrosis: promising prospects for drug discovery.肺纤维化模型的演变:药物发现的前景广阔。
Eur Respir Rev. 2024 Jan 17;33(171). doi: 10.1183/16000617.0127-2023. Print 2024 Jan 31.
8
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.从头设计高选择性整合素 αvβ6 和 αvβ8 的小分子抑制剂。
Nat Commun. 2023 Sep 13;14(1):5660. doi: 10.1038/s41467-023-41272-z.
9
Human Lung Organoids-A Novel Experimental and Precision Medicine Approach.人肺类器官——一种新型的实验和精准医学方法。
Cells. 2023 Aug 15;12(16):2067. doi: 10.3390/cells12162067.
10
design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.整合素αvβ6和αvβ8的高选择性微型蛋白抑制剂的设计
bioRxiv. 2023 Jun 12:2023.06.12.544624. doi: 10.1101/2023.06.12.544624.
Life (Basel). 2021 Jun 3;11(6):517. doi: 10.3390/life11060517.
4
Bio-assembling Macro-Scale, Lumenized Airway Tubes of Defined Shape via Multi-Organoid Patterning and Fusion.通过多器官类器官图案化和融合生物组装大尺寸、有腔气道管,具有规定形状。
Adv Sci (Weinh). 2021 Feb 8;8(9):2003332. doi: 10.1002/advs.202003332. eCollection 2021 May.
5
Targeting the AXL Receptor in Combating Smoking-related Pulmonary Fibrosis.靶向 AXL 受体防治与吸烟相关的肺纤维化。
Am J Respir Cell Mol Biol. 2021 Jun;64(6):734-746. doi: 10.1165/rcmb.2020-0303OC.
6
Role of interleukins in the pathogenesis of pulmonary fibrosis.白细胞介素在肺纤维化发病机制中的作用。
Cell Death Discov. 2021 Mar 15;7(1):52. doi: 10.1038/s41420-021-00437-9.
7
Challenges of applying multicellular tumor spheroids in preclinical phase.在临床前阶段应用多细胞肿瘤球体的挑战。
Cancer Cell Int. 2021 Mar 4;21(1):152. doi: 10.1186/s12935-021-01853-8.
8
A molecular cell atlas of the human lung from single-cell RNA sequencing.人类肺部单细胞 RNA 测序的分子细胞图谱。
Nature. 2020 Nov;587(7835):619-625. doi: 10.1038/s41586-020-2922-4. Epub 2020 Nov 18.
9
Spectrum of Fibrotic Lung Diseases.纤维化性肺疾病谱
N Engl J Med. 2020 Sep 3;383(10):958-968. doi: 10.1056/NEJMra2005230.
10
Human organoids: model systems for human biology and medicine.人类类器官:人类生物学和医学的模型系统。
Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584. doi: 10.1038/s41580-020-0259-3. Epub 2020 Jul 7.